Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2022 | The state of stem cell transplantation for multiple myeloma in Brazil

Vanderson Rocha • 28 Oct 2022
COSTEM 2022
Multiple Myeloma

Vanderson Rocha, MD, Fundação Pró-Sangue Hemocentro de São Paulo & Universidade de São Paulo, Sao Paulo, Brazil, describes current issues patients with multiple myeloma face receiving stem cell transplantation in Brazil. Despite transplantation being a key treatment strategy, only one in five patients with multiple myeloma will be able to receive a transplant due to a lack of transplant units and resources. This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Vanderson Rocha

1:17
The benefits and drawbacks of cord blood transplantation
Vanderson Rocha • 28 Oct 2022
1:41
Bone marrow as a superior source of stem cells after PTCy-based haplo-HSCT
Vanderson Rocha • 28 Oct 2022

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals